Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine

Europe has approved Moderna's combined flu-COVID mRNA vaccine before the US, flipping the script on American regulatory speed. It's a win for European public health and a stinging rebuke to Washington's sluggish approval process. This approval came 3 months faster than the FDA's timeline for the same vaccine, and it outperforms #2 on this list in terms of regulatory efficiency for novel mRNA combinations.